These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1057683)

  • 21. Does exercise training during hemodialysis really improve dialysis efficacy?
    Hsieh RL; Lee WC
    Arch Phys Med Rehabil; 2007 Jan; 88(1):130; author reply 130-1. PubMed ID: 17207690
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of amrinone in terminal dialysis-dependent renal failure].
    Stengele E; Trenk D
    Med Klin (Munich); 1992 May; 87(5):278-80. PubMed ID: 1614376
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of increasing blood flow rate on dialysis adequacy in hemodialysis patients.
    Borzou SR; Gholyaf M; Zandiha M; Amini R; Goodarzi MT; Torkaman B
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):639-42. PubMed ID: 19587507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [5/12. Drugs and the dialysis patient].
    Koutny E; Motte G; Woronoff-Lemsi MC
    Soins; 2001; (657):51-2. PubMed ID: 12008607
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical outcomes of nocturnal dialysis.
    Sherer M
    Nephrol Nurs J; 2002 Oct; 29(5):487-8. PubMed ID: 12434455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug clearance in patients undergoing continuous arteriovenous hemofiltration.
    Rubino M
    Clin Pharm; 1985; 4(6):620. PubMed ID: 4075732
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment time and ultrafiltration rate are more important in dialysis prescription than small molecule clearance.
    Twardowski ZJ
    Blood Purif; 2007; 25(1):90-8. PubMed ID: 17170543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of dialysis membranes in elimination of uremic toxins].
    Grzeszczak W; Zukowska-Szczechowska E; Rutkowski B
    Przegl Lek; 1996; 53(5):439-42. PubMed ID: 8754410
    [No Abstract]   [Full Text] [Related]  

  • 29. [A concentration measuring error-induced calculation error in determining uric acid clearance in dialysis: a simulation study].
    Jäger B; Biebler KE; Kraatz G
    Z Urol Nephrol; 1990 Nov; 83(11):603-8. PubMed ID: 2100086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urea rebound and residual renal function in the calculation of Kt/V and protein catabolic rate.
    Albouze G; Yanai M; Calamai M; Testou D; Jungers P; Man NK
    Kidney Int Suppl; 1993 Jun; 41():S278-81. PubMed ID: 8320937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Calcium metabolism before and during hemodialysis].
    Buchali K; Seeger W; Müller P
    Z Urol Nephrol; 1982 Jan; 75(1):31-4. PubMed ID: 7064590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of dyphylline elimination by uremic patients.
    Lee CC; Wang LH; Majeske BL; Marbury TC
    J Pharmacol Exp Ther; 1981 May; 217(2):340-4. PubMed ID: 7229976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quantitative evaluation of dialysis treatment. The priority of urea kinetic modelling].
    Simeonov P
    Vutr Boles; 1984; 23(2):7-12. PubMed ID: 6377704
    [No Abstract]   [Full Text] [Related]  

  • 34. Dialysis treatment of acute chromium intoxication and comparative efficacy of peritoneal versus hemodialysis in chromium removal.
    Schiffl H; Weidmann P; Weiss M; Massry SG
    Miner Electrolyte Metab; 1982 Jan; 7(1):28-35. PubMed ID: 7169974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits of early initiation of dialysis.
    Bonomini V; Feletti C; Scolari MP; Stefoni S
    Kidney Int Suppl; 1985 Dec; 17():S57-9. PubMed ID: 3937938
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of poisoning by forced diuresis].
    Bräunlich H
    Dtsch Gesundheitsw; 1971 May; 26(20):940-7. PubMed ID: 5122706
    [No Abstract]   [Full Text] [Related]  

  • 37. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose.
    Vilar E; Wellsted D; Chandna SM; Greenwood RN; Farrington K
    Nephrol Dial Transplant; 2009 Aug; 24(8):2502-10. PubMed ID: 19240122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of the phenomenon of the redistribution of aminoglycosides in their monitoring and dosage calculation in patients in the terminal stage of kidney failure undergoing systematic hemodialysis treatment].
    Siniukhin VN; Darenkov AF; Stetsiuk EA; Nikolaeva NP; Iarmolinskiĭ IS
    Urol Nefrol (Mosk); 1991; (1):43-7. PubMed ID: 1858206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of clinical pharmacokinetics in the causal treatment of acute drug poisoning].
    Lesne M
    Bull Mem Acad R Med Belg; 1981; 136(8-9):443-72. PubMed ID: 7042014
    [No Abstract]   [Full Text] [Related]  

  • 40. [The quantitative characteristics of the metabolism of antitumor compounds].
    Geodakian SV
    Izv Akad Nauk SSSR Biol; 1990; (1):15-21. PubMed ID: 2189918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.